A Texas woman has filed an Actos bladder cancer lawsuit in the state of Illinois against the manufacturer of the diabetes drug. Justine Zapalac alleges that she developed cancer of the bladder after taking Actos to treat her type II diabetes and that she would not have taken the medication had she been aware of the potential side effects.
Concerns about the link between Actos and bladder cancer arose in June 2011, when a study conducted in France found that Actos users were significantly more likely to be diagnosed with cancer of the bladder. In response to the study’s findings, health officials in both France and Germany announced that they would suspend sales of the drug in those countries.
Shortly afterward, the U.S. Food and Drug Administration issued an Actos warning stating that patients who were treated with the diabetes drug for more than one year were 40% more likely to develop bladder cancer. Although the drug is still being sold in the U.S., health officials in France decided to issue an Actos recall due to the evidence linking the drug to an increased risk of bladder cancer.
For more information about the link between Actos and bladder cancer or to find out whether you may be eligible to file a lawsuit, contact the lawyers at Heygood, Orr & Pearson by calling toll-free at 1-877-446-9001 or by filling out the free case evaluation form located on this page.